Literature DB >> 29923765

Physiological functions of ferroportin in the regulation of renal iron recycling and ischemic acute kidney injury.

Xueqiao Wang1, Xiaoqing Zheng1, Juanlian Zhang1, Shifeng Zhao1, Zhigang Wang2, Fudi Wang3, Wenjun Shang2, Jonathan Barasch4, Andong Qiu1,5.   

Abstract

Renal iron recycling preserves filtered iron from urinary excretion. However, it remains debated whether ferroportin (FPN), the only known iron exporter, is functionally involved in renal iron recycling and whether renal iron recycling is required for systemic iron homeostasis. We deleted FPN in whole nephrons by use of a Nestin-Cre and in the distal nephrons and collecting ducts, using a Ksp-Cre, and investigated its impacts on renal iron recycling and systemic iron homeostasis. FPN deletion by Nestin-Cre, but not by Ksp-Cre, caused excess iron retention and increased ferritin heavy chain (FTH1) specifically in the proximal tubules and resulted in the reduction of serum and hepatic iron. The systemic iron redistribution was aggravated, resulting in anemia and the marked downregulation of hepatic hepcidin in elderly FPN knockout (KO)/Nestin-Cre mice. Similarly, in iron-deficient FPN KO/Nestin-Cre mice, the renal iron retention worsened anemia with the activation of the erythropoietin-erythroferrone-hepcidin pathway and the downregulation of hepatic hepcidin. Hence, FPN likely located at the basolateral membrane of the proximal tubules to export iron into the circulation and was required for renal iron recycling and systemic iron homeostasis particularly in elderly and iron-deficient mice. Moreover, FPN deletion in the proximal tubules alleviated ischemic acute kidney injury, possibly by upregulating FTH1 to limit catalytic iron and by priming antioxidant mechanisms, indicating that FPN could be deleterious in the pathophysiology of ischemic acute kidney injury (AKI) and thus may be a potential target for the prevention and mitigation of ischemic AKI.

Entities:  

Keywords:  acute kidney injury; ferroportin; iron reabsorption; ischemia/reperfusion

Mesh:

Substances:

Year:  2018        PMID: 29923765      PMCID: PMC6230726          DOI: 10.1152/ajprenal.00072.2018

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  47 in total

Review 1.  Cellular iron: ferroportin is the only way out.

Authors:  Tomas Ganz
Journal:  Cell Metab       Date:  2005-03       Impact factor: 27.287

2.  Nestin-expressing cells in the gut give rise to enteric neurons and glial cells.

Authors:  J Belkind-Gerson; A Carreon-Rodriguez; L Andrew Benedict; C Steiger; A Pieretti; N Nagy; J Dietrich; A M Goldstein
Journal:  Neurogastroenterol Motil       Date:  2012-09-23       Impact factor: 3.598

3.  A novel mammalian iron-regulated protein involved in intracellular iron metabolism.

Authors:  S Abboud; D J Haile
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

4.  Hepcidin Mitigates Renal Ischemia-Reperfusion Injury by Modulating Systemic Iron Homeostasis.

Authors:  Yogesh Scindia; Paromita Dey; Abhinav Thirunagari; Huang Liping; Diane L Rosin; Matteo Floris; Mark D Okusa; Sundararaman Swaminathan
Journal:  J Am Soc Nephrol       Date:  2015-03-18       Impact factor: 10.121

5.  Serum Iron Protects from Renal Postischemic Injury.

Authors:  Céline Vaugier; Mariane T Amano; Jonathan M Chemouny; Michael Dussiot; Claire Berrou; Marie Matignon; Sanae Ben Mkaddem; Pamella H M Wang; Aurélie Fricot; Thiago T Maciel; Damien Grapton; Jacques R R Mathieu; Carole Beaumont; Marie-Noëlle Peraldi; Carole Peyssonnaux; Laurent Mesnard; Eric Daugas; François Vrtovsnik; Renato C Monteiro; Olivier Hermine; Yelena Z Ginzburg; Marc Benhamou; Niels O S Camara; Martin Flamant; Ivan C Moura
Journal:  J Am Soc Nephrol       Date:  2017-08-07       Impact factor: 10.121

6.  Differential expression of the intermediate filament protein nestin during renal development and its localization in adult podocytes.

Authors:  Jing Chen; Scott Boyle; Min Zhao; Wei Su; Keiko Takahashi; Linda Davis; Mark Decaestecker; Takamune Takahashi; Matthew D Breyer; Chuan-Ming Hao
Journal:  J Am Soc Nephrol       Date:  2006-03-29       Impact factor: 10.121

7.  Ferroportin expression in haem oxygenase 1-deficient mice.

Authors:  Rafał R Starzyński; François Canonne-Hergaux; Małgorzata Lenartowicz; Wojciech Krzeptowski; Alexandra Willemetz; Agnieszka Styś; Joanna Bierła; Piotr Pietrzak; Tomasz Dziaman; Paweł Lipiński
Journal:  Biochem J       Date:  2013-01-01       Impact factor: 3.857

8.  The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis.

Authors:  Adriana Donovan; Christine A Lima; Jack L Pinkus; Geraldine S Pinkus; Leonard I Zon; Sylvie Robine; Nancy C Andrews
Journal:  Cell Metab       Date:  2005-03       Impact factor: 27.287

9.  Megalin-dependent cubilin-mediated endocytosis is a major pathway for the apical uptake of transferrin in polarized epithelia.

Authors:  R Kozyraki; J Fyfe; P J Verroust; C Jacobsen; A Dautry-Varsat; J Gburek; T E Willnow; E I Christensen; S K Moestrup
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

10.  Smad1/5 is required for erythropoietin-mediated suppression of hepcidin in mice.

Authors:  Chia-Yu Wang; Amanda B Core; Susanna Canali; Kimberly B Zumbrennen-Bullough; Sinan Ozer; Lieve Umans; An Zwijsen; Jodie L Babitt
Journal:  Blood       Date:  2017-04-24       Impact factor: 22.113

View more
  12 in total

1.  Endothelial prolyl hydroxylase 2 is necessary for angiotensin II-mediated renal fibrosis and injury.

Authors:  Yongzhen Zhao; Heng Zeng; Bo Liu; Xiaochen He; Jian-Xiong Chen
Journal:  Am J Physiol Renal Physiol       Date:  2020-07-27

Review 2.  Iron Chelation as a Potential Therapeutic Strategy for AKI Prevention.

Authors:  Shreyak Sharma; David E Leaf
Journal:  J Am Soc Nephrol       Date:  2019-09-25       Impact factor: 10.121

Review 3.  Ferritins in Kidney Disease.

Authors:  Kayla McCullough; Subhashini Bolisetty
Journal:  Semin Nephrol       Date:  2020-03       Impact factor: 5.299

Review 4.  Targeting ferroptosis in ischemia/reperfusion renal injury.

Authors:  Komal Thapa; Thakur Gurjeet Singh; Amarjot Kaur
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-08-03       Impact factor: 3.195

Review 5.  Bone morphogenic proteins in iron homeostasis.

Authors:  Xia Xiao; Víctor M Alfaro-Magallanes; Jodie L Babitt
Journal:  Bone       Date:  2020-06-23       Impact factor: 4.398

6.  Coordination of iron homeostasis by bone morphogenetic proteins: Current understanding and unanswered questions.

Authors:  Allison L Fisher; Jodie L Babitt
Journal:  Dev Dyn       Date:  2021-05-25       Impact factor: 3.780

Review 7.  The Cross-Link between Ferroptosis and Kidney Diseases.

Authors:  Jingyu Wang; Yi Liu; Yaqing Wang; Li Sun
Journal:  Oxid Med Cell Longev       Date:  2021-05-03       Impact factor: 6.543

Review 8.  Physiological and pathophysiological mechanisms of hepcidin regulation: clinical implications for iron disorders.

Authors:  Yang Xu; Víctor M Alfaro-Magallanes; Jodie L Babitt
Journal:  Br J Haematol       Date:  2020-12-14       Impact factor: 8.615

9.  Changes in the Selected Antioxidant Defense Parameters in the Blood of Patients after High Resolution Computed Tomography.

Authors:  Amira Bryll; Wirginia Krzyściak; Anna Jurczak; Robert Chrzan; Anna Lizoń; Andrzej Urbanik
Journal:  Int J Environ Res Public Health       Date:  2019-04-26       Impact factor: 3.390

Review 10.  Abnormal Iron and Lipid Metabolism Mediated Ferroptosis in Kidney Diseases and Its Therapeutic Potential.

Authors:  Xiaoqin Zhang; Xiaogang Li
Journal:  Metabolites       Date:  2022-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.